Insider · CIK 0001825323
Alexandra Kropotova
directorofficer
Files at IBIO (iBio, Inc.), SABS (SAB Biotherapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | SABS SAB Biotherapeutics, Inc. | FTax withholding Common Stock | -473 | - | - | 41,853 | 24 d ago |
| Dec 11, 2025 | SABS SAB Biotherapeutics, Inc. | FTax withholding Common Stock | -988 | - | - | 44,284 | Dec 12, 2025 |
| Nov 20, 2025 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +13,500 | $0.00 | $0 | 13,500 | Nov 24, 2025 |
| Sep 19, 2025 | SABS SAB Biotherapeutics, Inc. | FTax withholding Common Stock | -1,977 | - | - | 45,272 | Sep 22, 2025 |
| Aug 26, 2025 | SABS SAB Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +2,400,000 | $0.00 | $0 | 2,400,000 | Aug 28, 2025 |
| Mar 27, 2025 | SABS SAB Biotherapeutics, Inc. | FTax withholding Common Stock | -1,179 | - | - | 47,249 | Apr 1, 2025 |
| Dec 18, 2024 | SABS SAB Biotherapeutics, Inc. | FTax withholding Common Stock | -9,072 | - | - | 48,428 | Dec 31, 2024 |
| Nov 21, 2024 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +18,900 | $0.00 | $0 | 18,900 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.